CT上肝脏表面结节度的全自动可解释测量:用于肝纤维化分期的效用
该回顾性研究纳入480例多病因肝病患者,在增强CT上自动测量肝脏表面结节度(LSN)并与手动工具评分比较。自动LSN评分随纤维化分期递增,鉴别显著纤维化(≥F2)、进展期纤维化(≥F3)和肝硬化(F4)的AUC分别为73.9%、82.5%和87.8%。作者认为全自动LSN测量可能有助于早期干预和人群研究。
要点
- 自动LSN评分随纤维化分期递增:F0为1.64±1.13,F4为4.21±2.94。
- 鉴别肝硬化(F4)的AUC为87.8%,阈值为2.18,敏感度86.5%、特异度79.5%。
- 自动测量约需45秒,手动测量约需2分钟。
核心结论
- 全自动LSN测量保留了鉴别进展期纤维化和肝硬化的预测能力;作者认为其可能有助于早期干预和人群研究,并能自动预测纤维化分期。
研究设计与样本
- 回顾性研究,数据集来自Institution-A于2000-2016年收集的多病因肝病患者(METAVIR F0-F4),共480例(男304例、女176例,平均年龄49±9岁),在增强CT体积上自动测量LSN并与手动工具评分比较。
诊断标准与关键数值
- 自动LSN鉴别显著纤维化(≥F2)的AUC为73.9%,阈值为1.51,敏感度85.2%、特异度73.3%。
- 自动LSN鉴别进展期纤维化(≥F3)的AUC为82.5%,阈值为1.73,敏感度84.2%、特异度79.5%。
- 自动LSN鉴别肝硬化(F4)的AUC为87.8%,阈值为2.18,敏感度86.5%、特异度79.5%。
- 自动LSN评分区分进展期纤维化(p<.001)和肝硬化(p<.001)具有统计学意义。
临床应用与阅片要点
- 作者认为全自动LSN测量可能有助于早期干预和人群研究。
- 全自动方法可在约45秒内自动预测纤维化分期,而手动测量LSN约需2分钟。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: In the United States, cirrhosis was the 12th leading cause of death in 2016. Despite end-stage cirrhosis being irreversible, earlier stages of hepatic fibrosis can be reversed via early diagnosis and intervention. The objective is to investigate the utility of a fully automated technique to measure liver surface nodularity (LSN) for staging hepatic fibrosis (stages F0-F4).
MATERIALS AND METHODS: In this retrospective study, a dataset consisting of patients with multiple etiologies of liver disease collected at Institution-A (METAVIR F0-F4, 2000-2016) was used. The LSN was automatically measured in contrast-enhanced CT volumes and compared against scores from a manual tool. Area under the receiver operating characteristics curve (AUC) was used to distinguish between clinically significant fibrosis (≥ F2), advanced fibrosis (≥F3), and end-stage cirrhosis (F4).
RESULTS: The study sample had 480 patients (304 men, 176 women, mean age, 49±9). Automatically derived LSN scores progressively increased with the fibrosis stage: F0 (1.64 [mean]±1.13 [standard deviation]), F1 (2.16±2.39), F2 (2.17±2.55), F3 (2.23±2.52), and F4 (4.21±2.94). For discriminating significant fibrosis (≥F2), advanced fibrosis (≥F3), and cirrhosis (F4), the automated tool achieved ROC AUCs of 73.9%, 82.5%, and 87.8% respectively. The sensitivity and specificity for significant fibrosis (nodularity threshold 1.51) was 85.2% and 73.3%, advanced fibrosis (nodularity threshold 1.73) was 84.2% and 79.5%, and cirrhosis (nodularity threshold 2.18) was 86.5% and 79.5%. Statistical tests revealed that the automated LSN scores distinguished patients with advanced fibrosis (p<.001) and cirrhosis (p<.001).
CONCLUSION: The fully automated LSN measurement retained its predictive power for distinguishing between advanced fibrosis and cirrhosis. The clinical impact is that the fully automated LSN measurement may be useful for early interventions and population-based studies. It can automatically predict the fibrosis stage in ∼45 s in comparison to the ∼2 min needed to manually measure the LSN in a CT volume.
引用
- Mathai TS, Lubner MG, Pickhardt PJ, et al. Fully Automated and Explainable Measurement of Liver Surface Nodularity in CT: Utility for Staging Hepatic Fibrosis. Acad Radiol. 2024. PMID: 39379241. doi:10.1016/j.acra.2024.09.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。